Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer

Abstract

Hepatoblasts are bipotent progenitors of both hepatocytes and cholangiocytes. The lack of stable in vitro culture systems for such cells makes it necessary to generate liver progenitor cell lines by means of immortalization. In this study, we describe the long-term behaviour of a clone of simian foetal hepatic progenitor cells immortalized by Simian virus 40 (SV40) large T-antigen (T-Ag) flanked by loxP sites. Immortalization was associated with the re-expression of telomerase activity, which decreased at late passages (population doubling 120) after more than a year in culture. This decrease was concomitant to telomere shortening and karyotypic instability. However, the chromosomes carrying the p53 gene remained intact and long-term immortalized progenitor cells maintained contact inhibition and proliferative properties. They also displayed the features of a normal bipotent phenotype. We constructed a retroviral vector expressing an inducible Cre recombinase and transferred it into the immortalized progenitors. Activation of the Cre recombinase by 4-hydroxy-tamoxifen induced SV40 T-Ag excision, leading to the death of cells expressing Cre recombinase. Immortalized progenitors at late passages stopped growing and eventually disappeared after transplantation into the livers of immunocompromised mice. These cells provide a novel model to study hepatic differentiation and carcinogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ali SH and DeCaprio JA . (2001). Semin. Cancer Biol., 11, 15–23.

  • Allain JE, Dagher I, Mahieu-Caputo D, Loux N, Andreoletti M, Westerman K, Briand P, Franco D, Leboulch P and Weber A . (2002). Proc. Natl. Acad. Sci. USA, 99, 3639–3644.

  • Blackburn EH . (1991). Nature, 350, 569–573 review.

  • Blasco MA, Lee HW, Rizen M, Hanahan D, Dopinho R and Greider CW . (1997). Ciba Found. Symp., 211, 160–170.

  • Blumrich M, Zeyen-Blumrich U, Pagels P and Petzinger E . (1994). Eur. J. Cell. Biol., 64, 339–347.

  • Bryan TM and Reddel RR . (1997). Eur. J. Cancer, 33, 767–773.

  • Casillas MA, Brotherton SL, Andrews LG, Ruppert JM and TollefsBol TO . (2003). Gene, 316, 57–65.

  • Challita PM and Kohn DB . (1994). Proc. Natl. Acad. Sci. USA, 91, 2567–2571.

  • Colucci F, Soudais C, Rosmaraki E, Vanes L, Tybulewicz VLJ and Di Santo JP . (1999). J. Immunol., 162, 2761–2765.

  • Counter C, Avilion A, LeFreuvre C, Stewart N, Greider C, Harley C and Bacchetti S . (1992). EMBO J., 5, 1921–1929.

  • Counter C, Hahn W, Wei W, Dickinson Caddle S, Beijersbergen R, Lansdorp P, Sedivy J and Weinberg E . (1998). Proc. Natl. Acad. Sci. USA, 95, 14723–14728.

  • Dabeva MD, Laconi E, Oren R, Petkov PM, Hurston E and Shafritz DA . (1998). Cancer Res., 58, 5825–5834.

  • de Lange T . (2002). Oncogene, 21, 532–540 review.

  • Dunham MA, Neumann AA, Fasching CL and Reddel RR . (2000). Nat. Genet., 26, 447–450.

  • Dutrillaux B, Biemont MC, Viegas-Pequignot E and Laurent C . (1979). Cytogenet. Cell. Genet., 23, 77–83.

  • Dutrillaux B and Couturier J . (1981). La pratique de l'analyse chromosomique. Mason: Paris.

    Google Scholar 

  • Erez N, Zamir E, Gour BJ, Blaschuk OW and Geiger B . (2004). Exp. Cell Res., 294, 366–378.

  • Grompe M, Laconi E and Shafritz DA . (1999). Semin. Liver Dis., 19, 7–14.

  • Hamad N, Banik S and Counter C . (2002). Oncogene, 21, 7121–7125.

  • Hayflick L and Moorhead PS . (1961). Exp. Cell Res., 25, 585–621.

  • Henson JD, Neumann AA, Yeager TR and Reddel RR . (2002). Oncogene, 21, 598–610.

  • Hoffschir F, Ricoul M and Dutrillaux B . (1988). Cytogenet. Cell Genet., 49, 264–268.

  • Hultdin M, Gronlund E, Norrback K, Eriksson-Lindstrom E, Just T and Roos G . (1998). Nucleic Acids Res., 26, 3651–3656.

  • Kakuo S, Asaoka K and Ide T . (1999). Biochem. Biophys. Res. Commun., 263, 308–314.

  • Kim BH, Sung SR, Choi EH, Kim YI, Kim KJ, Dong SH, Kim HJ, Chang YW, Lee JI and Chang R . (2000). Mol. Med., 32, 29–37.

  • Kobayashi N, Fujiwara T, Westerman K, Inoue Y, Sakagushi M, Nogushi H, Miyazaki M, Cai J, Tanaka N, Fox I and Leboulch P . (2000). Science, 287, 1258–1262.

  • Kyo S, Nakamura M, Kiyono T, Maida Y, Kanaya T, Tanaka M, Yatabe N and Inoue M . (2003). Am. J. Pathol., 163, 2259–2269.

  • Laconi S, Curreli F, Diana S, Pasciu D, De Filippo G, Sarma DS, Pani P and Laconi E . (1999). J. Hepatol., 31, 1069–1074.

  • Laconi S, Pillai S, Porcu PP, Shafritz DA, Pani P and Laconi E . (2001). Am. J. Pathol., 158, 771–777.

  • Leblanc V and May P . (2002). Medicine/Science, 18, 577–584.

  • Loayza D and De Lange T . (2003). Nature, 424, 1013–1018.

  • Lundberg A, Randell S, Stewart S, Elenbaas B, Hartwell K, Brooks M, Fleming M, Olsen J, Miller S, weinberg R and Hahn W . (2002). Oncogene, 21, 4577–4586.

  • Lustig AJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 3339–3341.

  • Mahieu-Caputo D, Allain JE, Branger J, Coulomb A, Delgado JP, Mainot S, Andreoletti M, Frydman R, Leboulch P, Di Santo JP, Capron F and Weber A . (2004). Human Gene Ther., 15, 1219–1228.

  • May P and May E . (1999). Oncogene, 18, 7621–7636.

  • Ouellette MM, Liao M, Herbert BS, Johnson M, Holt SE, Liss HS, Shay JW and Wright WE . (2000). J. Biol. Chem., 275, 10072–10076.

  • Pani P, Laconi S, Pillai S, Scintu F, Curreli F, Shafritz DA and Laconi E . (1999). J. Hepatol., 31, 354–359.

  • Pipas JM and Levine AJ . (2001). Semin. Cancer Biol., 11, 23–30.

  • Pommier JP, Gauthier L, Livartowski J, Galanaud P, Boue F, Dulioust A, Marce D, Ducray C, Sabatier L, Lebeau J and Boussin FD . (1997). Virology, 231, 148–154.

  • Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW and Wright WE . (2001). Genes Dev., 15, 398–403.

  • Rufer N, Dragowska W, Thornbury G, Roosnek E and Lansdorp PM . (1998). Nat. Biotechnol., 16, 743–747.

  • Seger YR, Garcia-Cao M, Piccinin S, Cunsolo CL, Doglioni C, Blasco MA, Hannon GJ and Maestro R . (2002). Cancer Cell., 2, 401–413.

  • Shimizu Y, Suzuki J, Terao K and Ishida T . (2003). Mech. Ageing Dev., 124, 237–244.

  • Steensel BV and De Lange T . (1997). Nature, 385, 740–743.

  • Steinert S, White DM, Zou Y, Shay JW and Wright W . (2002). Exp. Cell Res., 272, 146–152.

  • Stewart S, Hahn W, O'Connor B, Banner E, Lundberg A, Modha P, Mizuno H, Brooks M, Flemming N, Zimonjic D and Popescu N . (2002). Proc. Natl. Acad. Sci. USA, 99, 12606–12611.

  • Thomas D, Pritchard J, Davidson R, McKiernan P, Grundy RG and de Ville de Goyet J . (2003). Eur. J. Cancer, 39, 2200–2204.

  • Toouli C, Huschtscha L, Neumann A, Noble J, Colgin L, Hukku B and Reddel R . (2002). Oncogene, 21, 128–139.

  • Vallier L, Mancip J, Markossian S, Lukaszewicz A, Dehay C, Metzger D, Chambon P, Samarut J and Savatier P . (2001). Proc. Natl. Acad. Sci. USA, 98, 2467–2472.

  • Wang J, Ying Xie L, Allan S, Beach D and Hannon GJ . (1998). Genes Dev., 12, 1769–1774.

  • Woodworth CD, Kreider JW, Mengel L, Miller T, Meng YL and Isom H . (1988). Mol. Cell. Biol., 8, 4492–4501.

  • Wright WE and Shay JW . (1992a). Exp. Gerontol., 27, 383–389.

  • Wright WE and Shay JW . (1992b). Trends Genet., 8, 193–197.

  • Zhu J, Wang H, Bishop JM and Blackburn EH . (1999). Proc. Natl. Acad. Sci. USA, 96, 3723–3728.

Download references

Acknowledgements

We thank Drs D Mahieu and I Dagher for help in animal surgery, L Cam for helpful discussion and Mrs B Savary for assistance in artwork. This research was supported by the EC, QLK3CT 1999-00364, and grants from Inserm ATC Biothérapies, Association Française contre les Myopathies, the Fondation pour la Recherche Médicale, the Etablissement Français des Greffes, the ‘GIS Maladies Rares’ and the Institut Pasteur. JE Allain was supported by Fondation pour la Recherche Médicale.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Weber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delgado, JP., Parouchev, A., Allain, JE. et al. Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer. Oncogene 24, 541–551 (2005). https://doi.org/10.1038/sj.onc.1208089

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208089

Keywords

This article is cited by

Search

Quick links